Operating Lease, Right-of-Use Asset of Orthofix Medical Inc. from 01 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Orthofix Medical Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Dec 2025.
  • Orthofix Medical Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $22,279,000, a 29% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Orthofix Medical Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $22,279,000 +$5,041,000 +29% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $23,961,000 +$5,905,000 +33% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $24,859,000 +$6,280,000 +34% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $16,595,000 -$2,521,000 -13% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $17,238,000 -$2,631,000 -13% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $18,056,000 -$1,709,000 -8.6% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $18,579,000 -$1,855,000 -9.1% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $19,116,000 -$2,164,000 -10% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $19,869,000 +$13,081,000 +193% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $19,765,000 +$12,946,000 +190% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $20,434,000 +$13,843,000 +210% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $21,280,000 +$14,187,000 +200% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $6,788,000 +$3,633,000 +115% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $6,819,000 +$3,248,000 +91% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $6,591,000 +$2,436,000 +59% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $7,093,000 +$2,595,000 +58% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $3,155,000 -$1,685,000 -35% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 $3,571,000 -$1,401,000 -28% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $4,155,000 -$1,006,000 -19% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $4,498,000 -$1,032,000 -19% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $4,840,000 -$958,000 -17% 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q3 2020 $4,972,000 -$922,000 -16% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $5,161,000 -$1,192,000 -19% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $5,530,000 -$1,228,000 -18% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $5,798,000 -$14,402,000 -71% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q3 2019 $5,894,000 30 Sep 2019 10-Q 28 Oct 2019 2019 Q3
Q2 2019 $6,353,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $6,758,000 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $20,200,000 01 Jan 2019 10-K 25 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.